Published in Immunity, a recent study by researchers at the German Center for Neurodegenerative Diseases (DZNE) and the University of Bonn provides new insights into how targeting the NLRP3 inflammasome – a key regulator of the immune response – could modulate metabolic and mitochondrial function in microglia, enhancing their ability to clear amyloid-β and potentially slow the progression of Alzheimer’s disease... https://longevity.technology/news/reducing-neuroinflammation-may-provide-new-pathway-for-alzheimers-treatment/